Remove 2025 Remove Health Policy Remove Life Science
article thumbnail

What is a Consumer Health Company? Riffing Off of Deloitte’s Report on CHCs/A 2Q2025 Look at Self-Care Futures

Health Populi

While this report hit the virtual bookshelf about six months ago, I am revisiting it on this first day of the second quarter of 2025 because of its salience in this moment of uncertainties across our professional and personal lives — particularly related to health politics, global economics and trade, and the erosion of trust in institutions.

article thumbnail

COVID-19 Further Splits American Society as Trust Continues to Erode – a 5-Year Perspective from Pew

Health Populi

This was not the case five years later, Edelman learned earlier this year in the 2025 update : in this year’s mood seen as a Crisis of Grievance, most people were looking for compassion as a place of influence — not a formal position of power.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Measuring Progress for Life Sciences: Trust, Patient Access, and Prevention at a Fork in the Road of Public Health

Health Populi

How will we know if the life sciences sector is advancing in 2025? This is the question asked at the start of the report, a Research Brief: 2025 Indicators of Progress for the Life Sciences Sector, from the IQVIA Institute for Human Data Science (IQVIA). We start with the state of trust held by U.S.

article thumbnail

How Tariffs Could Wreak Havoc on Health Care Costs and Supply Chains in the U.S.

Health Populi

In the landscape of health care, then, we are concerned about tariffs’ impacts on the costs and supply chains of clinical supplies and equipment, stuff we spend capital and operational dollars on which include a portfolio of things from disposable supplies to pacemakers and digital imaging equipment, along with raw ingredients for medicines.